Atrial Fibrillation (AF) Clinical Trials in Boston, Massachusetts
6 recruitingBoston, Massachusetts
Showing 1–6 of 6 trials
Recruiting
Phase 2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Atrial Fibrillation (AF)
Regeneron Pharmaceuticals1,200 enrolled48 locationsNCT07175428
Recruiting
Early Phase 1
Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
Atrial Fibrillation (AF)
China National Center for Cardiovascular Diseases3,160 enrolled12 locationsNCT06615596
Recruiting
Not Applicable
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
Atrial Fibrillation (AF)Persistant Atrial Fibrillation
Boston Scientific Corporation699 enrolled41 locationsNCT07187115
Recruiting
Not Applicable
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
Atrial Fibrillation (AF)Persistent Atrial FibrillationParoxysmal Atrial Fibrillation (PAF)
Medtronic Cardiac Ablation Solutions400 enrolled30 locationsNCT07298473
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled734 locationsNCT05712200
Recruiting
Not Applicable
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
Atrial Fibrillation (AF)VTE
McMaster University920 enrolled14 locationsNCT06957366